Good post. I tend to agree with your sentiments.
"- how exactly, well that's a different question."
This is my consideration at present too. The options have to be either cancelled or exercised as a part of any full buyout scenario. I do not believe that MT & the board would attempt to force through a deal with no consideration for options (but I have been wrong before, on occasion).
Here is the spread on what was paid to various option holders in the Resapp deal for anyone that's interested:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-682
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.0¢ | $83.08K | 474.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 376717 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 144077 | 1 |
View Market Depth
| Last trade - 15.41pm 10/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |